Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Prostatic Neoplasms × Immunotherapy × 30 days × Clear all

Sponsor

Conditions

Melanoma 2 Carcinoma, Non-Small-Cell Lung 2 Small Cell Lung Carcinoma 1 Neoplasms, Glandular and Epithelial 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasms 1 Neoplasm, Residual 1 Lung Neoplasms 1 Liver Neoplasms 1 Liver Diseases 1 Digestive System Neoplasms 1 Digestive System Diseases 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Breast Neoplasms, Male 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

Magnetic Resonance Spectroscopy 25 Specimen Handling 23 enzalutamide 21 Prednisone 19 Androgen Antagonists 15 Abiraterone Acetate 15 apalutamide 13 Pluvicto 10 darolutamide 9 Radiosurgery 9 Leuprolide 9 X-Rays 8 Radiotherapy 8 cabazitaxel 7 abiraterone 7 Photons 7 Biopsy 7 prednylidene 6 gallium 68 PSMA-11 6 deltacortene 6 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 6 Glutamate Carboxypeptidase II 6 relugolix 5 luprolide acetate gel depot 5 bicalutamide 5 Goserelin 5 Docetaxel 5 Dexamethasone 5 Carboplatin 5 Brachytherapy 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡